(Q40639238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

angiogenesis inhibitor

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Irina Nesmelova

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

11

Arjan W Griffioen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Kevin H Mayo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Carolee Flader

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Balasz Hargittai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Daisy W J van der Schaft

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Loes I van Eijk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Dinesha Walek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Judy Haseman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Thomas R Hoye

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

28 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

7 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

45746-45752

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

Anginex, a designed peptide that inhibits angiogenesis

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

The cell biology of thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Crystal structure of the angiogenesis inhibitor endostatin at 1.5Aresolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Structure of tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Crystal structure of the TSP-1 type 1 repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Angiostatin binds ATP synthase on the surface of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Cell surface glypicans are low-affinity endostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Rocking the foundations of solid tumor growth by attacking the tumor's blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Anti-tumor activity of the novel angiogenesis inhibitor anginex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Improved Synthesis of the Boc and Fmoc Derivatives of 4-(2'-Aminoethyl)-6-dibenzofuranpropionic Acid: An Unnatural Amino Acid That Nucleates beta-Sheet Folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Tissue-type plasminogen activator is a multiligand cross-beta structure receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308608200

21 January 2018

Identifiers

DOI

10.1074/JBC.M308608200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12947097%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference